IP Library Granted Patent US 10,071,979
Granted Patent B2
US 10,071,979 · App. 14/687,286 · Granted Sep 11, 2018

Process of producing cycloalkylcarboxamido-indole compounds

Inventors: Gerald J. Tanoury (Marlborough, MA); Cristian Harrison (Beverly, MA); Benjamin Joseph Littler (Carlsbad, CA); Peter Jamison Rose (Littleton, MA); Robert Michael Hughes (San Diego, CA); Young Chun Jung (Lexington, MA); David Andrew Siesel (San Diego, CA); Elaine Chungmin Lee (Arlington, MA); Daniel T. Belmont (Grafton, MA); William A. Nugent (Noblesville, IN)
Assignee: Vertex Pharmaceuticals Incorporated
C07D317/46C07C209/74C07C225/06C07D209/12C07D317/60C07D405/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,071,979
App. No.
14/687,286
Granted
Sep 11, 2018
Kind
B2
Abstract

The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1), useful for treating CFTR mediated diseases such as cystic fibrosis.

Claims (81)

1. A method of preparing a compound of formula III:

wherein, independently for each occurrence:

R 2 is —R J , —OR J , —N(R J ) 2 , —NO 2 ,

halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

R 3 is C 1-6 aliphatic optionally substituted with OH, OP, —O—C 1-6 aliphatic, aryl, heteroaryl, —O-aryl, or —O-heteroaryl;

P is a protecting group; and

o is an integer from 0 to 3;

comprising the steps of:

a) reacting a compound of formula IIIA:

wherein, independently for each occurrence:

R 2 is —R J , —OR J , —N(R J ) 2 , —NO 2 ,

halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic; and

o is an integer from 0 to 3;

with a halogenating reagent in a first organic solvent to form a compound of formula IIIB:

wherein, independently for each occurrence:

R 2 is —R J , —OR J , —N(R J ) 2 , —NO 2 ,

halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

is an integer from 0 to 3; and

Hal is a halide;

b) reacting the compound of formula IIIB in a second organic solvent with a compound of formula IIIC:

wherein:

P is a protecting group;

followed by reduction and treatment with acid to form a compound of formula IIID:

wherein:

R 2 is —R J , —OR J , —N(R J ) 2 , —NO 2 ,

halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

o is an integer from 0 to 3;

Hal is a halide;

P is a protecting group; and

A ⊖ is an anion;

c) neutralizing a compound of formula IIID in the presence of a base to form a compound of formula IIID-a:

wherein:

R 2 is —R J , —OR J , —N(R J ) 2 , —NO 2 ,

halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

o is an integer from 0 to 3;

Hal is a halide; and

P is a protecting group;

d) reacting a compound of formula IIID-a in a third organic solvent with a compound of formula IIIE:

wherein, independently for each occurrence:

R 3 is a C 1-6 aliphatic optionally substituted with OH, OP, —O—C 1-6 aliphatic, aryl, heteroaryl, —O-aryl, or —O-heteroaryl;

in the presence of a catalyst to form a compound of formula III.

2. The method of claim 1 , wherein in formula IIIA, o is 1 and R 2 is F.

3. The method of claim 1 , wherein in step a), the halogenating reagent is N-bromosuccinimide.

4. The method of claim 1 , wherein in step a), the first organic solvent is an aprotic solvent.

5. The method of claim 1 , wherein in step a), the first organic solvent is ethyl acetate.

6. The method of claim 1 , wherein step a) takes place at about 2° C. to 42° C.

7. The method of claim 1 , wherein in formula IIIB, o is 1, R 2 is F, and Hal is Br.

8. The method of claim 1 , wherein in formula IIIC, P is benzyl.

9. The method of claim 1 , wherein in step b), the second organic solvent is an aprotic solvent.

10. The method of claim 1 , wherein in step b), the second organic solvent is toluene.

11. The method of claim 1 , wherein in step b), the reaction with a compound of formula IIIC takes place at about 60° C. to 100° C.

12. The method of claim 1 , wherein in step b), reduction is carried out with hydrogen.

13. The method of claim 1 , wherein in step b), the acid is p-toluenesulfonic acid.

14. The method of claim 1 , wherein in formula IIID, o is 1, R 2 is F, Hal is Br, A ⊖ is Tos − , and P is benzyl.

15. The method of claim 1 , wherein in formula IIIE, R 3 is C(CH 3 ) 2 CH 2 O(benzyl).

16. The method of claim 1 , wherein in step c) the base is an inorganic base.

17. The method of claim 1 , wherein in step d), the third organic solvent is an aprotic solvent.

18. The method of claim 1 , wherein in step d), the third organic solvent is acetonitrile.

19. The method of claim 1 , wherein step d) takes place at about 60° C. to 100° C.

20. The method of claim 1 , wherein in step d), the catalyst is a palladium catalyst.

21. The method of claim 1 , wherein in step d), the catalyst is selected from palladium(II)acetate, Pd(dppf)Cl 2 , Pd(dba) 2 , tetrakis(triphenylphosphine)palladium(0), (MeCN) 2 PdCl 2 , or tris(dibenzylideneacetone)dipalladium(0).

22. The method of claim 1 , wherein in step d), the catalyst is palladium(II)acetate.

23. A compound of formula III:

or a salt thereof,

wherein, independently for each occurrence:

R 2 is —R J , —OR J , —N(R J ) 2 , —NO 2 ,

halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , or —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

R 3 is C 1-6 aliphatic optionally substituted with OH, OP, —O—C 1-6 aliphatic, aryl, heteroaryl, —O-aryl, or —O-heteroaryl;

P is a protecting group; and

o is an integer from 0 to 3.

24. The compound or salt of claim 23 , wherein o is 1 and R 2 is F.

25. The compound or salt of claim 23 , wherein R 3 is C(CH 3 ) 2 CH 2 O(benzyl).

26. The compound or salt of claim 23 , wherein P is acetyl, benzoyl, benzyl, methoxyethoxymethyl, dimethoxytrityl, methoxymethyl, methoxytrityl, p-methoxybenzyl, pivaloyl, tetrahydropyranyl, trityl, or trimethylsilyl.

27. The compound or salt of claim 26 , wherein P is benzyl.

28. The compound or salt of claim 23 , wherein the compound is

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2018
From: NUGENT, WILLIAM A.
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 045331/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2015
From: TANOURY, GERALD J.; HARRISON, CRISTIAN; LITTLER, BENJAMIN JOSEPH; ROSE, PETER JAMISON; HUGHES, ROBERT MICHAEL; JUNG, YOUNG CHUN; SIESEL, DAVID ANDREW; LEE, ELAINE CHUNGMIN; BELMONT, DANIEL T.
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 036721/0367 →
Continuity (10)
Division 13642642
Provisional Application 61333870 · May 12, 2010
Provisional Application 61329510 · Apr 29, 2010
Provisional Application 61329500 · Apr 29, 2010
Provisional Application 61329493 · Apr 29, 2010
Provisional Application 61327095 · Apr 22, 2010
Provisional Application 61327091 · Apr 22, 2010
Provisional Application 61327057 · Apr 22, 2010
Provisional Application 61327099 · Apr 22, 2010
Related Publication 20150218122A1 · Aug 6, 2015
Cited By (6)
US 50,453 US 12,214,083 US 12,269,831 US 12,324,802 US 12,458,635 US 12,508,231